Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPICIN for Endocarditis staphylococcal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where RIFAMPICIN was used for Endocarditis staphylococcal.

Most Reported Side Effects for RIFAMPICIN

Side Effect Reports % Deaths Hosp.
Drug reaction with eosinophilia and systemic symptoms 27 15.1% 2 12
Pyrexia 23 12.9% 3 12
Drug interaction 16 8.9% 3 6
Dyspnoea 13 7.3% 8 9
Vomiting 13 7.3% 4 9
Drug-induced liver injury 12 6.7% 1 3
Nausea 11 6.2% 3 7
Pruritus 10 5.6% 6 5
Alanine aminotransferase increased 8 4.5% 0 6
Anaemia 8 4.5% 2 5
Aspartate aminotransferase increased 8 4.5% 0 6
Erythema 8 4.5% 2 4
Lymphadenopathy 8 4.5% 1 6
Abdominal pain 7 3.9% 0 7
Altered state of consciousness 7 3.9% 1 6

Other Indications for RIFAMPICIN

Pulmonary tuberculosis (40) Tuberculosis (38) Product used for unknown indication (19) Device related infection (6) Meningitis tuberculous (5)

Other Drugs Used for Endocarditis staphylococcal

DAPTOMYCIN (150) VANCOMYCIN (137) RIFAMPIN (72) GENTAMICIN (48) LINEZOLID (41) CEFAZOLIN (30) OXACILLIN (21) LEVOFLOXACIN (20) CUBICIN (19) CEFTAROLINE FOSAMIL (18)

Related Pages

RIFAMPICIN Full Profile All Endocarditis staphylococcal Drugs RIFAMPICIN Demographics RIFAMPICIN Timeline